Bioethicists and critics have questioned the omission. Columbia psychiatrist Robert Klitzman pointed to finasteride’s reported link to depression and urged full transparency; Arthur Caplan called for an independent assessment. Public anecdotes also remind readers that Trump previously acknowledged Propecia use — and a 2018 physician briefing listed a daily 1 mg dose.
Observers say knowing which medicines a president takes can matter for public trust. The White House maintains the memo is complete, while some experts want more clarity about the change in Propecia’s status.